PEPTONIC medical AB (publ) (XSAT: PMED)
Health Care · Pharmaceuticals · SE
Skr0.00
— today · — 1Y
PEPTONIC medical AB (publ) (XSAT: PMED) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.90M.
trading between 0.05 and 0.16.
Tweenvest scores PEPTONIC medical AB (publ) across four factors: quality 20/100, growth 0/100. Its strongest factor is quality.
PMED price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.90M
- Revenue (TTM)
- $1.13M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.00
- 52-week high
- Skr0.16
- 52-week low
- Skr0.05
- Avg volume (3M)
- —
- Shares outstanding
- 1.53B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,243.40 | -0.96% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.46 | +1.19% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.49 | -1.35% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.98 | -0.32% |
Figures last refreshed Aug 18, 2026.